Clostridium Chauvoei Bacterin Toxoid + Clostridium Novyi Bacterin Toxoid + Clostridium Perfringens Type C Bacterin Toxoid + Clostridium Perfringens Type D Bacterin Toxoid + Clostridium Septicum Bacterin Toxoid + Clostridium Sordellii Bacterin Toxoid + Moraxella Bovis Bacterin Toxoid
26 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
26
Total Reports
11
Deaths Reported
4230.0%
Death Rate
Active Ingredients
Clostridium Chauvoei Bacterin ToxoidClostridium Novyi Bacterin ToxoidClostridium Perfringens Type C Bacterin ToxoidClostridium Perfringens Type D Bacterin ToxoidClostridium Septicum Bacterin ToxoidClostridium Sordellii Bacterin ToxoidMoraxella Bovis Bacterin Toxoid
Administration Routes
UnknownSubcutaneous
Species Affected
Cattle 26
Most Affected Breeds
Cattle (other) 17
Aberdeen Angus 5
Crossbred Bovine/Cattle 2
Cattle (unknown) 2
Most Reported Reactions
Lack of efficacy - NOS 11
Death 10
Lack of efficacy (bacteria) - NOS 7
CULTURE/TITER DATA ABNORMAL 3
PR-LIVER, LESION(S) 2
Respiratory signs 1
INEFFECTIVE, ANTIBIOTIC 1
Tachypnoea 1
Fever 1
Anorexia 1
Lung sound 1
Laboured breathing 1
Outcome Breakdown
Outcome Unknown
15 (36.6%)
Died
11 (26.8%)
Recovered/Normal
8 (19.5%)
Ongoing
4 (9.8%)
Recovered with Sequela
3 (7.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.